Search details
1.
Liver-related complications before and after successful treatment of chronic hepatitis C virus infection in people with inherited bleeding disorders.
Haemophilia
; 29(1): 106-114, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36184751
2.
Viral hepatitis in haemophilia: historical perspective and current management.
Br J Haematol
; 195(2): 174-185, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33955555
3.
Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
Cochrane Database Syst Rev
; 4: CD011385, 2019 04 19.
Article
in English
| MEDLINE | ID: mdl-31002742
4.
Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions.
Cochrane Database Syst Rev
; 7: CD012293, 2018 07 02.
Article
in English
| MEDLINE | ID: mdl-29963686
5.
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A.
Hum Mol Genet
; 22(9): 1903-10, 2013 May 01.
Article
in English
| MEDLINE | ID: mdl-23372042
6.
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.
Blood
; 122(11): 1954-62, 2013 Sep 12.
Article
in English
| MEDLINE | ID: mdl-23926300
7.
Comorbidities and inhibitors in adult patients with haemophilia: issues, costs and management strategies.
Eur J Haematol
; 95 Suppl 80: 1-15, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26492487
8.
Bleeding spectrum in children with moderate or severe von Willebrand disease: Relevance of pediatric-specific bleeding.
Am J Hematol
; 90(12): 1142-8, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26375306
9.
Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
Cochrane Database Syst Rev
; (12): CD011385, 2015 Dec 24.
Article
in English
| MEDLINE | ID: mdl-26704192
10.
Inhibitor incidence after intensive FVIII replacement for surgery in mild and moderate haemophilia A: a prospective national study in the Netherlands.
Br J Haematol
; 157(6): 747-52, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22533635
11.
Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study.
Res Pract Thromb Haemost
; 6(6): e12741, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-36051543
12.
How I treat age-related morbidities in elderly persons with hemophilia.
Blood
; 114(26): 5256-63, 2009 Dec 17.
Article
in English
| MEDLINE | ID: mdl-19837978
13.
Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972-2019.
J Thromb Haemost
; 19(10): 2394-2406, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34117710
14.
Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001-2018.
J Thromb Haemost
; 19(3): 645-653, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33217158
15.
ADAMTS-13 and bleeding phenotype in von Willebrand disease.
Res Pract Thromb Haemost
; 4(8): 1331-1339, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-33313472
16.
Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study.
BMJ Open
; 9(4): e022719, 2019 04 23.
Article
in English
| MEDLINE | ID: mdl-31015264
17.
IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A.
Br J Haematol
; 142(4): 644-52, 2008 Aug.
Article
in English
| MEDLINE | ID: mdl-18510679
18.
Circulating Angiogenic Mediators in Patients with Moderate and Severe von Willebrand Disease: A Multicentre Cross-Sectional Study.
Thromb Haemost
; 118(1): 152-160, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29304535
19.
Management of cardiovascular disease in aging persons with haemophilia.
Hamostaseologie
; 37(3): 196-201, 2017 Aug 07.
Article
in English
| MEDLINE | ID: mdl-27966004
20.
Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm™4).
Thromb Res
; 141: 69-76, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26970716